期刊文献+

Bβ448野生型及突变型纤维蛋白原稳定转染细胞系的建立 被引量:1

Establishment of stably transfected cell line expressing BβArg448 or BβLys448 fibrinogen
下载PDF
导出
摘要 目的构建野生型(BβArg448)和突变型(BβLys448)纤维蛋白原稳定表达细胞系,为进一步研究BβArg448Lys基因多态性的病理生理学意义及相关蛋白功能研究提供实验基础。方法以含纤维蛋白原野生型Bβ链cDNA全长的表达载体pMLP-FGB(448G)为模板,采用PCR定点突变技术构建BβLys448表达载体,即突变型质粒pMLP-FGB(448A)。应用脂质体转染及药物加压筛选的方法,将纤维蛋白原Aα链、野生型/突变型Bβ链、γ链表达载体共同转染至CHO-K1细胞,RT-PCR检测各条链mRNA的表达。结果野生型及突变型纤维蛋白原稳定转染细胞系在转录水平构建成功。结论野生型及突变型纤维蛋白原稳定转染细胞等在转录水平构建成功,为进一步体外研究BβArg448Lys所致纤维蛋白原的结构与功能异常奠定了基础。 Objective To investigate the effect of BβArg448Lys polymorphism on the function of fibrinogen,and to establish the stably transfected cell line expressing fibrinogen with BβArg448 and BβLys448 polymorphism.Methods Mutant fibrinogen Bβ chain cDNA(BβLys448) pMLP-FGB(448A) was generated from wild type Bβ chain cDNA(BβArg448) pMLP-FGB(448G),which contains the entire fibrinogen Bβ chain cDNA using site-directed mutagenesis method.The expression vectors encoding the entire fibrinogen Aα chain,wild type/ mutant type Bβ chain and γ chain cDNA were introduced into CHO-K1 cells respectively using Lipofectamine.The expression of all three chains in the transfected cell line was tested by RT-PCR.Results The stably transfected cell line expressing fibrinogen with BβArg448 and BβLys448 polymorphism was successfully established,which provide a useful cell model to the further functional study.Conclusion The stably transfected cell line expressing fibrinogen with BβArg448Lys and BβLys448 polymorphism was successfully established,which provide a useful cell model to the further functional study.
出处 《首都医科大学学报》 CAS 2012年第2期187-192,共6页 Journal of Capital Medical University
基金 国家重点基础研究发展计划项目(2009CB522107) 国家自然科学基金国际(地区)合作与交流(30810103904) 国家自然科学基金(81070042) 北京市自然科学基金(7082012)项目资助~~
关键词 纤维蛋白原 定点突变 稳定转染细胞系 fibrinogen site-directed mutagenesis stable transfected cell line
  • 相关文献

参考文献18

  • 1Brummel K E,Butenas S,Mann K G. An integrated study of fibrinogen during blood coagulation[J].Journal of Biological Chemistry,1999,(32):22862-22870.
  • 2Roy S N,Mukhopadhyay G,Redman C M. Regulation of fibrinogen assembly.Transfection of Hep G2 cells with B beta cDNA specifically enhances synthesis of the three component chains of fibrinogen[J].Journal of Biological Chemistry,1990,(11):6389-6393.
  • 3Carter A M,Ossei-Gerning N,Wilson I J. Association of the platelet Pl(A) polymorphism of glycoprotein Ⅱb/Ⅲa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease[J].Circulation,1997,(05):1424-1431.
  • 4Behague I,Poirier O,Nicaud V. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction.The ECTIM Study.Etude Cas-Temoins sur l Infarctus du Myocarde[J].Circulation,1996,(03):440-449.
  • 5Ong K L,Tso A W,Cherny S S. A genetic variant in the gene encoding fibrinogen beta chain predicted development of hypertension in Chinese men[J].Thrombosis and Haemostasis,2010,(04):728-735.
  • 6Weisel J W. Fibrinogen and fibrin[J].Advances in Protein Chemistry,2005.247-299.
  • 7Litvinov R I,Gorkun O V,Galanakis D K. Polymerization of fibrin:Direct observation and quantification of individual B:b knob-hole interactions[J].Blood,2007,(01):130-138.
  • 8Carlisle C R,Coulais C,Namboothiry M. The mechanical properties of individual,electrospun fibrinogen fibers[J].Biomateriale,2009,(06):1205-1213.
  • 9Bowley S R,Okumura N,Lord S T. Impaired protofibril formation in fibrinogen gamma N308K is due to altered D:D and "A:a” interactions[J].Biochemistry,2009,(36):8656-8663.
  • 10Siegerink B,Rosendaal F R,Algra A. Genetic variation in fibrinogen;its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke[J].Journal of Thrombosis and Haemostasis,2009,(03):385-390.

同被引文献20

  • 1Jin L,Jin H,Zhang G,et al.Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction w oth lumbrokinase[J].Clin Hemorhrol M icrocirc,2000,23(224):213-218.
  • 2WHO.Intemational statistical classification of diseases and related health problems[M].10th ed.Geneva:World Health Organization,2010.
  • 3van Hylckama Vieg A,Rosendaal F R.High levels of fibrinogen are associated w ith the rise of deep venous thrombosis mainly in the erderly[J].J Thromb Haemost,2013,1(12):2677-2678.
  • 4Yukizawa Y,Inaba Y,Watanabe S,et al.Association betw een venous thrombembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170patients undergoing total hip arthroplasty[J].Aeta Orthop,2012,83(1):14-21.
  • 5Stang L J.D-dimer and fibrinogen/fibrin degradation products[J].M ethods M ol Biol,2013,992:415-427.
  • 6Wong P,Baglin T.Epidemiology,risk factors and sequelae of venous thromboembolism[J].Phlebology,2012,27(2):2-11.
  • 7Barba R,Zapatero A,Losa J E,et al.Venous thromboembolism in acutely ill hospitalized medical patients[J].Thromb Res,2010,126(4):276-279.
  • 8Levy Y D,Hardwick M E,Copp S N,et al.Thrombosis incidence in unilateral vs simultaneous bilateral total knee arthroplasty w ith compression device prophylaxis[J].J Arthroplasty,2012,8(12):570-580.
  • 9Fiengo L,Bucci F,Patrizi G,et al.Postpartum deep vein thrombosis and plmonary embolism in tw in pregnancy:undertaking of clinical symptoms leading to massive complications[J].Thromb J,2013,11(1):11-14.
  • 10苏里亚,徐光,彭禹.老年卧床患者下肢深静脉血流动力学改变与血栓形成的关系[J].首都医科大学学报,2009,30(3):396-398. 被引量:12

引证文献1

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部